• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秋水仙碱治疗急性痛风。风险与益处的重新评估。

Colchicine in acute gout. Reassessment of risks and benefits.

作者信息

Roberts W N, Liang M H, Stern S H

出版信息

JAMA. 1987 Apr 10;257(14):1920-2.

PMID:3820512
Abstract

Colchicine is an effective and relatively specific treatment for acute gout and has a long, venerable history. Serious toxic reactions to colchicine could be prevented if guidelines for its use were followed strictly, but because of its relatively infrequent use and conflicting recommendations, considerable toxic effects might occur and still be undetected by passive surveillance. A review of a teaching hospital's four years' experience showed two deaths (2% incidence) due to inappropriate use. Colchicine has the smallest benefit-to-toxicity ratio of drugs that are effective for acute gout. This article gives specific recommendations for the use of colchicine in different clinical settings.

摘要

秋水仙碱是治疗急性痛风的一种有效且相对特异的药物,其历史悠久且备受尊崇。如果严格遵循秋水仙碱的使用指南,对其严重的毒性反应是可以预防的,但由于其使用相对不频繁且存在相互矛盾的推荐意见,可能会出现相当多的毒性作用,而被动监测仍可能无法察觉。对一家教学医院四年经验的回顾显示,因使用不当导致了两例死亡(发生率为2%)。秋水仙碱在对急性痛风有效的药物中,其效益 - 毒性比最小。本文给出了在不同临床环境下使用秋水仙碱的具体建议。

相似文献

1
Colchicine in acute gout. Reassessment of risks and benefits.秋水仙碱治疗急性痛风。风险与益处的重新评估。
JAMA. 1987 Apr 10;257(14):1920-2.
2
Reassessing the safety of intravenous and compounded injectable colchicine in acute gout treatment.重新评估静脉注射和复方注射用秋水仙碱在急性痛风治疗中的安全性。
Expert Opin Drug Saf. 2007 Nov;6(6):625-9. doi: 10.1517/14740338.6.6.625.
3
Safety and effectiveness of colchicine by intravenous administration in the treatment of gout.静脉注射秋水仙碱治疗痛风的安全性和有效性。
J Clin Pharmacol J New Drugs. 1969 Nov-Dec;9(6):410-2.
4
Use of intravenous colchicine in patients with acute gout.急性痛风患者静脉注射秋水仙碱的应用。
Am Fam Physician. 2000 Apr 15;61(8):2343-4.
5
Colchicine in acute gout.秋水仙碱治疗急性痛风
BMJ. 2003 Nov 29;327(7426):1275-6. doi: 10.1136/bmj.327.7426.1275.
6
Renal function predicts colchicine toxicity: guidelines for the prophylactic use of colchicine in gout.肾功能可预测秋水仙碱毒性:痛风患者秋水仙碱预防性使用指南。
J Rheumatol. 1991 Feb;18(2):264-9.
7
Review: systemic toxicity associated with the intravenous administration of colchicine--guidelines for use.综述:秋水仙碱静脉给药相关的全身毒性——使用指南
J Rheumatol. 1988 Mar;15(3):495-9.
8
Deaths associated with inappropriate intravenous colchicine administration.与不适当静脉注射秋水仙碱相关的死亡。
J Emerg Med. 2002 May;22(4):385-7. doi: 10.1016/s0736-4679(02)00430-4.
9
Does colchicine work? The results of the first controlled study in acute gout.秋水仙碱有效吗?急性痛风的首个对照研究结果。
Aust N Z J Med. 1987 Jun;17(3):301-4. doi: 10.1111/j.1445-5994.1987.tb01232.x.
10
Adherence to guidelines and the screening tool of older persons' potentially inappropriate prescriptions criteria for colchicine dosing for gout treatment in beneficiaries of the Nova Scotia Seniors' Pharmacare Program.新斯科舍省老年人药物护理计划受益人群中痛风治疗秋水仙碱剂量的老年人潜在不适当处方标准指南及筛查工具的依从性。
Clin Ther. 2015 Oct 1;37(10):2339-46. doi: 10.1016/j.clinthera.2015.08.016. Epub 2015 Sep 29.

引用本文的文献

1
Comprehensive GC-MS Characterization and Histochemical Assessment of Various Parts of Three Species from Bulgarian Flora.保加利亚植物群中三种植物不同部位的综合气相色谱-质谱表征及组织化学评估
Plants (Basel). 2025 Jan 18;14(2):270. doi: 10.3390/plants14020270.
2
Transcriptomic analysis of the anti-inflammatory effect of extract on acute gouty arthritis.提取物对急性痛风性关节炎抗炎作用的转录组学分析
Front Pharmacol. 2022 Oct 14;13:1035101. doi: 10.3389/fphar.2022.1035101. eCollection 2022.
3
Determination of Colchicine in Pharmaceutical Formulations, Traditional Extracts, and Ultrasonication-Based Extracts of Pleniflorum (L.) Using Regular and Greener HPTLC Approaches: A Comparative Evaluation of Validation Parameters.
采用常规和更环保的高效薄层色谱法测定重瓣萱草(L.)制剂、传统提取物和超声提取物中的秋水仙碱:验证参数的比较评估
Plants (Basel). 2022 Jul 3;11(13):1767. doi: 10.3390/plants11131767.
4
Colchicine Blocks Tubulin Heterodimer Recycling by Tubulin Cofactors TBCA, TBCB, and TBCE.秋水仙碱通过微管蛋白辅助因子TBCA、TBCB和TBCE阻断微管蛋白异二聚体的循环利用。
Front Cell Dev Biol. 2021 Apr 22;9:656273. doi: 10.3389/fcell.2021.656273. eCollection 2021.
5
MNBDR: A Module Network Based Method for Drug Repositioning.MNBDR:一种基于模块网络的药物重新定位方法。
Genes (Basel). 2020 Dec 27;12(1):25. doi: 10.3390/genes12010025.
6
Activated charcoal significantly reduces the amount of colchicine released from Gloriosa superba in simulated gastric and intestinal media.活性炭在模拟胃和肠道介质中能显著减少秋水仙碱从大丽花中释放的量。
Clin Toxicol (Phila). 2017 Sep;55(8):914-918. doi: 10.1080/15563650.2017.1325897. Epub 2017 May 23.
7
Improved growth and colchicine concentration in Gloriosa superba on mycorrhizal inoculation supplemented with phosphorus-fertilizer.接种菌根并补充磷肥后,嘉兰的生长及秋水仙碱浓度得到改善。
Afr J Tradit Complement Altern Med. 2014 Jan 28;11(2):439-46. doi: 10.4314/ajtcam.v11i2.30. eCollection 2014.
8
Defining 'surveillance' in drug safety.定义药物安全中的“监测”。
Drug Saf. 2012 May 1;35(5):347-57. doi: 10.2165/11597590-000000000-00000.
9
Colchicine-associated ring mitosis in liver biopsy and their clinical implications.肝活检中与秋水仙碱相关的环状有丝分裂及其临床意义。
J Clin Gastroenterol. 2008 Oct;42(9):1060-2. doi: 10.1097/MCG.0b013e31803815b4.
10
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.口服泼尼松龙/对乙酰氨基酚与口服吲哚美辛/对乙酰氨基酚联合疗法治疗急性痛风样关节炎的比较:一项双盲、随机、对照试验。
Ann Emerg Med. 2007 May;49(5):670-7. doi: 10.1016/j.annemergmed.2006.11.014. Epub 2007 Feb 5.